mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.29 |
2e-06 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-06 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.28 |
4e-05 |